CDK7 antibody (pThr170) (FITC)
Quick Overview for CDK7 antibody (pThr170) (FITC) (ABIN1956378)
Target
See all CDK7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- pThr170
-
Specificity
- Human CDK7.
-
Purification
- Affinity purified
-
Immunogen
-
KLH-conjugated synthetic phosphopeptide around Thr170 of human Cdk7.
Type of Immunogen: Synthetic phospho-peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: DB, ELISA, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, no preservatives added
-
Preservative
- Without preservative
-
Handling Advice
- Aliquot to avoid repeated freezing and thawing.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Expiry Date
- 6 months
-
-
- CDK7 (Cyclin-Dependent Kinase 7 (CDK7))
-
Alternative Name
- CDK7
-
Background
-
Name/Gene ID: CDK7
Subfamily: CDC2/CDK
Family: Protein Kinase
Synonyms: CDK7, 39 kDa protein kinase, CDK-activating kinase, CDK-activating kinase 1, CDKN7, Cell division protein kinase 7, Cyclin-dependent kinase 7, HCAK, Protein kinase, Mpk-7, Serine/threonine kinase stk1, CAK, CAK1, Crk4, Kinase subunit of CAK, MO15, p39 Mo15, p39MO15, STK1 -
Gene ID
- 1022
-
Pathways
- Cell Division Cycle, DNA Damage Repair, Intracellular Steroid Hormone Receptor Signaling Pathway, Mitotic G1-G1/S Phases, M Phase
Target
-